Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹173 Cr.
Stock P/E
22.3
P/B
—
Current Price
₹101
Book Value
₹ 0
Face Value
10
52W High
₹121
52W Low
₹ 63
Dividend Yield
0%

Neochem Bio Solution Overview

Business

Neochem Bio Solutions Ltd. operates in the chemicals sector in India. Given its name "Bio Solutions," the company is likely engaged in the development, manufacturing, and marketing of specialty chemicals, with a potential focus on sustainable, biological, or environmentally friendly chemical solutions. This could include products for various industries such as agriculture, water treatment, industrial processes, or pharmaceuticals, where specialized and often performance-enhancing chemical inputs are required. The core business model would involve B2B sales of these specialized chemical products, generating revenue through direct sales or distribution networks to industrial clients.

Revenue Mix

Information regarding specific key business segments or a detailed revenue mix is not provided in the prompt. As a specialty chemical company, it likely serves multiple end-user industries, but the breakdown of revenue contributions from these segments is unavailable.

Industry

The Indian chemical industry is diverse and growing, characterized by a mix of large integrated players and numerous smaller, specialized companies. The specialty chemicals segment, in particular, is experiencing strong growth driven by increasing demand from end-user industries and a global shift towards India as a manufacturing hub. Neochem Bio Solutions, operating in "Bio Solutions," likely positions itself within a niche of the specialty chemicals market, potentially focusing on environmentally conscious or biologically derived products. Its positioning relative to larger, more diversified chemical giants would likely be as a specialized player, competing on product innovation, technical expertise, and specific application knowledge rather than broad scale or commoditized products.

MOAT

Without specific details, potential competitive advantages for Neochem Bio Solutions could include:

Proprietary Formulations/R&D: Specialization in "Bio Solutions" suggests investments in R&D to develop unique or patented chemical formulations, creating products difficult for competitors to replicate.

Customer Stickiness: For specialty chemicals, once a product is integrated into a client's process, switching costs can be high due to re-testing, re-formulation, and regulatory approvals.

Regulatory Expertise: Navigating specific environmental or biological product regulations effectively can be a barrier to entry for new competitors.

However, without detailed information, the strength and durability of these potential advantages cannot be definitively assessed.

Growth Drivers

Key factors that could drive growth for Neochem Bio Solutions over the next 3-5 years include:

Increasing Demand for Specialty Chemicals: Continued industrialization and growth in sectors like agriculture, water management, and healthcare will drive demand for specialized chemical inputs.

Shift Towards Sustainable/Bio-based Solutions: Growing environmental awareness and regulations are pushing industries to adopt greener chemical alternatives, a segment where "Bio Solutions" companies can thrive.

Product Portfolio Expansion: Successful R&D and introduction of new, innovative products catering to emerging market needs.

Export Opportunities: Leveraging India's cost-competitiveness and manufacturing capabilities to tap into global markets for specialty chemicals.

Risks

Raw Material Price Volatility: Fluctuations in the cost of key raw materials can impact profitability, as chemical companies are often price-takers for their inputs.

Intense Competition: The specialty chemical sector in India is competitive, with both domestic and international players.

Regulatory Changes: Evolving environmental and chemical safety regulations could necessitate costly changes in manufacturing processes or product formulations.

R&D Success Dependency: As a "Bio Solutions" company, growth might be heavily reliant on successful and timely development of new, commercially viable products.

Economic Downturns: A slowdown in end-user industries can directly impact demand for specialty chemicals.

Management & Ownership

Specific details about the promoters, management quality, or detailed ownership structure are not provided in the prompt. Typically, Indian companies like Neochem Bio Solutions are promoter-led, with the founding family or group holding a significant stake and guiding the company's long-term vision. Management quality would depend on their industry experience, strategic acumen, and execution capabilities, which cannot be assessed without further information.

Outlook

Neochem Bio Solutions Ltd. operates in the promising specialty chemicals sector, with a potential strategic focus on "Bio Solutions" which aligns with global trends towards sustainability. This niche positioning could offer growth opportunities, particularly if the company excels in R&D and develops proprietary products with high customer stickiness. However, the company faces inherent risks associated with raw material price volatility, intense competition, and the capital-intensive nature of chemical manufacturing and R&D. Its ability to scale, innovate effectively, and navigate regulatory complexities will be crucial for its sustained success. The lack of detailed information on its financial performance, specific product portfolio, and market share makes a definitive assessment challenging, but the company's sector and apparent specialization suggest both potential and execution challenges.

Neochem Bio Solution Share Price

Live · NSE · Inception: 2017
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Neochem Bio Solution Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Neochem Bio Solution Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 48 61 84
Other Income 1 1 2
Total Income 49 62 86
Total Expenditure 44 55 71
Operating Profit 5 7 15
Interest 2 3 4
Depreciation 1 1 1
Exceptional Income / Expenses 0 0 0
Profit Before Tax 2 3 10
Provision for Tax 0 1 3
Profit After Tax 1 2 8
Adjustments 0 0 0
Profit After Adjustments 1 2 8
Adjusted Earnings Per Share 1.1 1.5 6.6

Neochem Bio Solution Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 12 20
Minority's Interest 0 0 0
Borrowings 12 18 14
Other Non-Current Liabilities 1 1 1
Total Current Liabilities 29 33 44
Total Liabilities 51 64 79
Fixed Assets 15 19 19
Other Non-Current Assets 4 7 7
Total Current Assets 32 39 53
Total Assets 51 64 79

Neochem Bio Solution Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0
Cash Flow from Operating Activities -1 2 3
Cash Flow from Investing Activities -3 -8 -2
Cash Flow from Financing Activities 4 6 -1
Net Cash Inflow / Outflow -0 0 -0
Closing Cash & Cash Equivalent 0 0 0

Neochem Bio Solution Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.13 1.54 6.64
CEPS(Rs) 2.41 2.59 7.77
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 8.48 10.27 16.91
Core EBITDA Margin(%) 8.77 9.8 15.58
EBIT Margin(%) 7.5 9.21 16.35
Pre Tax Margin(%) 3.15 4.37 12.19
PAT Margin (%) 2.23 2.95 9.21
Cash Profit Margin (%) 4.75 4.94 10.79
ROA(%) 2.12 3.14 10.84
ROE(%) 13.33 17.96 48.82
ROCE(%) 10.54 14.15 27.34
Receivable days 109.19 94.48 92.18
Inventory Days 113.09 98.91 90.99
Payable days 156.95 130.08 100.44
PER(x) 0 0 0
Price/Book(x) 0 0 0
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.66 0.65 0.5
EV/Core EBITDA(x) 6.55 5.79 2.8
Net Sales Growth(%) 0 26.89 37.66
EBIT Growth(%) 0 55.86 144.44
PAT Growth(%) 0 67.89 330.28
EPS Growth(%) 0 36.48 330.28
Debt/Equity(x) 3.26 2.78 1.8
Current Ratio(x) 1.09 1.17 1.21
Quick Ratio(x) 0.58 0.62 0.67
Interest Cover(x) 1.72 1.9 3.93
Total Debt/Mcap(x) 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +38% — — —
Operating Profit CAGR +114% — — —
PAT CAGR +300% — — —
Share Price CAGR — — — —
ROE Average +49% +27% +27% +27%
ROCE Average +27% +17% +17% +17%

Neochem Bio Solution Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 66.72 %
FII 0.18 %
DII (MF + Insurance) 15.82 %
Public (retail) 17.28 %
# Mar 2026
Promoter 66.72
FII 0.18
DII 15.82
Public 17.28
Others 0
Total 100

Neochem Bio Solution Peer Comparison

Chemicals Edit Columns

Neochem Bio Solution Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Neochem Bio Solution Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 27%
  • Debtor days have improved from 130.08 to 100.44days.
  • Company has reduced debt.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp